Colgate-Palmolive Company $CL Stock: Vise Technologies Inc. Grows Holdings

Vise Technologies Inc. boosted its stake in Colgate-Palmolive Company (NYSE:CL) by 10.4% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 82,381 shares of the company’s stock after buying an additional 7,755 shares during the quarter. Vise Technologies Inc.’s holdings in Colgate-Palmolive were worth $7,029,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of the company. State Street Corp increased its stake in Colgate-Palmolive by 97.4% during the 2nd quarter. State Street Corp now owns 94,195,992 shares of the company’s stock worth $8,635,889,000 after buying an additional 46,476,510 shares in the last quarter. Bank of New York Mellon Corp raised its holdings in shares of Colgate-Palmolive by 8.1% during the second quarter. Bank of New York Mellon Corp now owns 13,532,417 shares of the company’s stock valued at $1,240,652,000 after acquiring an additional 1,010,872 shares during the last quarter. First Eagle Investment Management LLC lifted its position in shares of Colgate-Palmolive by 1.1% in the second quarter. First Eagle Investment Management LLC now owns 8,205,699 shares of the company’s stock valued at $752,298,000 after acquiring an additional 88,917 shares in the last quarter. Bank of America Corp DE lifted its position in shares of Colgate-Palmolive by 17.4% in the first quarter. Bank of America Corp DE now owns 6,637,597 shares of the company’s stock valued at $565,722,000 after acquiring an additional 986,063 shares in the last quarter. Finally, Amundi lifted its position in shares of Colgate-Palmolive by 19.9% in the second quarter. Amundi now owns 6,218,257 shares of the company’s stock valued at $570,090,000 after acquiring an additional 1,033,918 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.

More Colgate-Palmolive News

Here are the key news stories impacting Colgate-Palmolive this week:

• Positive Sentiment: Colgate-Palmolive reported third-quarter sales growth of 4.6%, exceeded earnings expectations, narrowed its full-year sales outlook, and raised its margin and EPS guidance. The results suggest pricing, productivity efforts, and steady demand are offsetting inflationary and operating-cost pressures. Colgate-Palmolive sales rise 4.6% and it lifts margin and EPS outlook
• Positive Sentiment: Management highlighted resilient global demand and premium product innovation, supporting expectations for continued organic growth despite a challenging cost environment. CL Q3 deep dive: global demand and premium innovation support steady growth amid cost pressures
• Positive Sentiment: Morgan Stanley raised its price target to $111 from $104 and maintained an Overweight rating. BNP Paribas Exane also lifted its target to $108 from $97 while reaffirming Outperform, reflecting greater confidence after the quarterly beat. Colgate-Palmolive Analysts Boost Their Forecasts After Upbeat Q3 Earnings
• Positive Sentiment: Royal Bank of Canada raised its target to $105 from $104 and retained an Outperform rating, while Wells Fargo increased its target to $95 from $90. The broad target revisions indicate improved earnings expectations, even though analyst conviction varies.
• Neutral Sentiment: JPMorgan lowered its target modestly to $102 from $104 but kept an Overweight rating. Barclays likewise maintained a Hold rating, signaling that some analysts view the recent rally and valuation as largely reflecting the improved outlook.
• Neutral Sentiment: Colgate-Palmolive appointed Akash Parekh to lead India marketing following Gunjit Jain’s departure. The leadership transition could affect execution in an important growth market, but no immediate financial impact was reported. Colgate-Palmolive Picks Akash Parekh To Lead India Marketing
• Negative Sentiment: Investors continue to monitor margin pressure and lingering questions about profit growth. Wells Fargo’s Equal Weight rating and target below the recent trading level underscore concerns that cost inflation and a relatively full valuation could limit further upside.

Colgate-Palmolive Stock Up 2.4%

CL stock opened at $97.59 on Tuesday. The company has a market cap of $77.79 billion, a price-to-earnings ratio of 24.00, a PEG ratio of 4.44 and a beta of 0.33. The company has a current ratio of 1.03, a quick ratio of 0.67 and a debt-to-equity ratio of 13.82. Colgate-Palmolive Company has a 12 month low of $74.54 and a 12 month high of $99.33. The firm has a 50-day moving average of $89.67 and a two-hundred day moving average of $89.72.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, October 30th. The company reported $0.97 earnings per share for the quarter, topping analysts’ consensus estimates of $0.93 by $0.04. The business had revenue of $5.37 billion for the quarter, compared to analyst estimates of $5.34 billion. Colgate-Palmolive had a net margin of 9.68% and a return on equity of 464.63%. The business’s revenue was up 4.6% on a year-over-year basis. During the same period last year, the company posted $0.91 EPS. As a group, analysts forecast that Colgate-Palmolive Company will post 3.89 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Investors of record on Tuesday, October 20th will be issued a $0.53 dividend. This represents a $2.12 annualized dividend and a dividend yield of 2.2%. The ex-dividend date of this dividend is Tuesday, October 20th. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 84.13%.

Analysts Set New Price Targets

A number of analysts have recently issued reports on CL shares. Morgan Stanley lifted their price target on Colgate-Palmolive from $104.00 to $111.00 and gave the stock an “overweight” rating in a research note on Monday. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and issued a $101.00 price objective (up from $99.00) on shares of Colgate-Palmolive in a research note on Monday, August 3rd. Jefferies Financial Group restated a “hold” rating and issued a $89.00 price objective (up from $88.00) on shares of Colgate-Palmolive in a report on Monday, August 3rd. UBS Group lifted their target price on shares of Colgate-Palmolive from $106.00 to $112.00 and gave the stock a “buy” rating in a research note on Monday. Finally, BNP Paribas Exane reaffirmed an “outperform” rating and set a $108.00 target price (up from $97.00) on shares of Colgate-Palmolive in a research note on Monday. Thirteen investment analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $100.78.

Insider Buying and Selling

In other Colgate-Palmolive news, Director John T. Cahill sold 4,170 shares of the company’s stock in a transaction on Thursday, August 6th. The stock was sold at an average price of $93.37, for a total value of $389,352.90. Following the completion of the sale, the director directly owned 28,373 shares in the company, valued at $2,649,187.01. This represents a 12.81% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, COO Panagiotis Tsourapas sold 10,000 shares of the company’s stock in a transaction on Monday, August 24th. The shares were sold at an average price of $92.05, for a total value of $920,500.00. Following the completion of the sale, the chief operating officer owned 64,901 shares of the company’s stock, valued at approximately $5,974,137.05. The trade was a 13.35% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Company insiders own 0.43% of the company’s stock.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company (NYSE: CL) is a global consumer products company focused on oral care, personal care, home care and pet nutrition. Its portfolio includes toothpaste, toothbrushes, mouthwash, liquid hand soap, body wash, deodorants, household cleaning products and pet food and treats.

The company markets well-known brands such as Colgate, Palmolive, elmex, meridol, Softsoap, Irish Spring, Ajax, Protex and Hill’s Science Diet. Colgate-Palmolive also provides veterinary and nutritional products through Hill’s Pet Nutrition, which serves pet owners and animal health professionals.

Founded in 1806 by William Colgate, the company developed from a soap and candle business into a diversified consumer goods manufacturer.